Beta Alethine in Treating Patients With Myeloma

• Status: Unknown status
• Trial end date: 1969-12-31

Summary

RATIONALE: Biological therapies such as beta alethine use different ways to stimulate the immune system and stop cancer cells from growing.

PURPOSE: Phase I/II trial to study the effectiveness of beta alethine in treating patients who have myeloma.

• Phase: Phase 1/Phase 2

Details

• Lead Sponsor: LifeTime Pharmaceuticals
• Treatments: Cysteamine